Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Total 13F shares
-
81,954,269
-
Share change
-
+378,639
-
Total reported value
-
$3,297,744,791
-
Put/Call ratio
-
66%
-
Price per share
-
$40.24
-
Number of holders
-
404
-
Value change
-
-$89,660,583
-
Number of buys
-
206
-
Number of sells
-
210
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q4 2024
As of 31 Dec 2024 Viking Therapeutics, Inc. - COMMON STOCK (VKTX) had 404 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 81,954,269 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, MORGAN STANLEY, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, BRAIDWELL LP, and AMERIPRISE FINANCIAL INC.
This table shows 405 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.